Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Cascorbi

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Clinical Pharmacology and Therapeutics|February 15, 2016
Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?M Ingelman-Sundberg, I Cascorbi
Cancer Research|November 1, 1996
A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibilityI Cascorbi, J Brockmöller, I Roots
Cancer Research|June 30, 2001
Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10I Cascorbi, I Roots, J Brockmöller
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Molecular-epidemiological aspects of carcinogenesis: the role of xenobiotic metabolizing enzymesI Cascorbi, J Brockmöller, I Roots
Ecotoxicology and Environmental Safety|April 1, 1995
Effects of a heterogeneous set of xenobiotics on RNA synthesis of yeast cellsI Cascorbi, E R Lochmann, R Roth
Cancer Research|September 1, 1996
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer riskJ Brockmöller, I Cascorbi, R Kerb, et al.
Analytical Biochemistry|August 1, 1997
Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutationsP M Mrozikiewicz, O Landt, I Cascorbi, et al.
Archives of General Psychiatry|February 7, 2001
Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sampleM Dettling, I Cascorbi, I Roots, et al.
Pharmacogenetics|August 1, 1997
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clampingP M Mrozikiewicz, I Cascorbi, J Brockmöller, et al.
The Pharmacogenomics Journal|September 27, 2006
Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigensM Dettling, I Cascorbi, C Opgen-Rhein, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Clinical Pharmacology and Therapeutics|February 15, 2016
Pharmacogenomic or -epigenomic biomarkers in drug treatment: Two sides of the same medal?M Ingelman-Sundberg, I Cascorbi
Cancer Research|November 1, 1996
A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibilityI Cascorbi, J Brockmöller, I Roots
Cancer Research|June 30, 2001
Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10I Cascorbi, I Roots, J Brockmöller
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Molecular-epidemiological aspects of carcinogenesis: the role of xenobiotic metabolizing enzymesI Cascorbi, J Brockmöller, I Roots
Ecotoxicology and Environmental Safety|April 1, 1995
Effects of a heterogeneous set of xenobiotics on RNA synthesis of yeast cellsI Cascorbi, E R Lochmann, R Roth
Cancer Research|September 1, 1996
Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer riskJ Brockmöller, I Cascorbi, R Kerb, et al.
Analytical Biochemistry|August 1, 1997
Peptide nucleic acid-mediated polymerase chain reaction clamping allows allelic allocation of CYP1A1 mutationsP M Mrozikiewicz, O Landt, I Cascorbi, et al.
Archives of General Psychiatry|February 7, 2001
Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sampleM Dettling, I Cascorbi, I Roots, et al.
Pharmacogenetics|August 1, 1997
CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clampingP M Mrozikiewicz, I Cascorbi, J Brockmöller, et al.
The Pharmacogenomics Journal|September 27, 2006
Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigensM Dettling, I Cascorbi, C Opgen-Rhein, et al.
Pageof 9